Canary in the coal mine.

The unprecedented cost of CAR-T cells, which is likely the tip of the iceberg of future policy challenges regarding where to draw the line on the price of a human life, all without discouraging further awe-inspiring medical breakthroughs. | Jacobson, JAMA 2019